Results for tag: "Transplantation Drug"

The Transplantation Drug market is a subset of the Immunosuppressive Drug market, which is composed of drugs used to suppress the immune system in order to prevent organ rejection in transplant patients. These drugs are used to reduce the activity of the immune system, allowing the body to accept a transplanted organ. The most commonly used drugs are calcineurin inhibitors, such as cyclosporine and tacrolimus, and mTOR inhibitors, such as sirolimus and everolimus. Other drugs used in transplantation include mycophenolate mofetil, azathioprine, and corticosteroids. The Transplantation Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Novartis, Pfizer, Astellas, Bristol-Myers Squibb, Merck, and Sanofi. Show Less Read more